111 Total Liabilities and Share Holders Equity 2018-2024 | YI

111 total liabilities and share holders equity from 2018 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
111 Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $382
2023 $435
2022 $504
2021 $494
2020 $464
2019 $231
2018 $225
2017 $115
111 Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-12-31 $382
2024-09-30 $432
2024-06-30 $384
2024-03-31 $405
2023-12-31 $435
2023-09-30 $461
2023-06-30 $421
2023-03-31 $472
2022-12-31 $504
2022-09-30 $429
2022-06-30 $463
2022-03-31 $475
2021-12-31 $494
2021-09-30 $486
2021-06-30 $511
2021-03-31 $470
2020-12-31 $464
2020-09-30 $401
2020-06-30 $267
2020-03-31 $233
2019-12-31 $231
2019-09-30 $234
2019-06-30 $253
2019-03-31 $239
2018-09-30 $247
2017-12-31 $115
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.070B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.172B 59.16
Hims & Hers Health (HIMS) United States $12.418B 139.02
Tempus AI (TEM) United States $12.340B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $3.751B 59.77
Privia Health (PRVA) United States $2.761B 190.75
Hinge Health (HNGE) United States $2.719B 0.00
Enovis (ENOV) United States $1.822B 10.27
Schrodinger (SDGR) United States $1.572B 0.00
Phreesia (PHR) United States $1.547B 0.00
Clover Health Investments (CLOV) United States $1.468B 0.00
Azenta (AZTA) United States $1.401B 65.30
Omnicell (OMCL) United States $1.370B 24.15
10x Genomics (TXG) United States $1.282B 0.00
Fulgent Genetics (FLGT) United States $0.630B 0.00
Claritev (CTEV) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.477B 140.50
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.347B 778.33
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
Pulmonx (LUNG) United States $0.122B 0.00
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.095B 0.00
CareCloud (CCLD) United States $0.088B 3.44
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00